SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mendis Roshan

(Last)

(First)

(Middle)

C/O SABRE CORPORATION

3150 SABRE DRIVE

(Street)

SOUTHLAKE

76092

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/08/2020

3. Issuer Name and Ticker or Trading Symbol
Sabre Corp [ SABR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Executive Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	53,369⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options to Purchase Common Stock	⁽²⁾	03/13/2025	Common Stock	13,626	$22.15	D
Options to Purchase Common Stock	⁽³⁾	03/15/2026	Common Stock	11,915	$27.79	D
Options to Purchase Common Stock	⁽⁴⁾	03/15/2027	Common Stock	19,350	$22.01	D
Options to Purchase Common Stock	⁽⁵⁾	03/15/2028	Common Stock	22,840	$22.03	D
Options to Purchase Common Stock	⁽⁶⁾	03/15/2029	Common Stock	17,375	$21.35	D
Options to Purchase Common Stock	⁽⁷⁾	03/13/2030	Common Stock	27,027	$8.33	D

Explanation of Responses:

1. Includes a grant of 16,484 restricted share unit awards on 9/15/2017 that will vest 100% on 9/15/2020, subject to the reporting person's continued employment on the vesting date.

2. The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant of March 13, 2015 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date.

3. The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant of March 15, 2016 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date.

4. The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant of March 15, 2017 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date.

5. The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant of March 15, 2018 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date.

6. The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant of March 15, 2019 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date.

7. The options were granted on March 13, 2020 and vest and become exercisable in three equal installments of 33 1/3% on March 15, 2021, March 15, 2022 and March 15, 2023, subject to the reporting person's continued employment with the Issuer through each vesting date.

Remarks:

	/s/ Steve Milton, as attorney-in-fact for Roshan Mendis	06/17/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.